Theraflu Expressmax Severe Cold And Flu Caplets Tablet, Coated
Product Images NDC 0067-8145

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Theraflu Expressmax Severe Cold And Flu Caplets (NDC 0067-8145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Haleon Us Holdings Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12982_theraflu Expressmax Cold And Flu Caps_20ct.jpg (12982 Theraflu Expressmax Cold And Flu Caps 20ct)

12982_theraflu Expressmax Cold And Flu Caps_20ct.jpg (12982 Theraflu Expressmax Cold And Flu Caps 20ct)
This is a drug information section. The drug is a combination of several active ingredients such as acetaminophen, dextromethorphan, guaifenesin, and phenylephrine. This drug can help relieve symptoms of the common cold, flu, and other respiratory illnesses. It has warnings against taking more than the recommended dosage of acetaminophen, as it can cause liver damage. People with certain medical conditions are advised to consult their doctors before using this drug. The drug is intended for people 12 years and older. If symptoms persist, people are also advised to seek medical attention.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.